Abstract
Due to its neural tissue specificity S-100b is considered as a screening marker of cerebral injury in head trauma patients. However, the occurrence and relevance of an increased S-100b serum level in minor head trauma (MHT) is still debated. Therefore, the purpose of our study was to evaluate the diagnostic utility of S-100b measurements in a level I trauma center emergency room (ER). Eighty patients presenting with clinical symptoms of MHT (GCS score of 13–15, transitory loss of consciousness, amnesia, nausea) were prospectively recruited. Blood samples were drawn at 0 h, 6 h and 24 h after admission, and a cerebral computed tomography (CT) was performed. The reference group consisted of 10 patients with severe head injury (GCS score < 8), the control group of 20 healthy volunteers. Concentrations of S-100b in serum were determined by an immunoluminometric assay. The results were compared with the plasma levels of polymorphonuclear (PMN) elastase as an established general trauma marker.
In the MHT group, the S-100b serum level revealed 1.26 ± 0.57 ng/ml at study entry (73.46 ± 47.53 min after trauma). In comparison, the S-100b concentration was significantly elevated in patients with severe head trauma (5.26 ± 1.65 ng/ml, p = 0.009), but no significant difference became evident in relation to the control group (0.05 ± 0.01 ng/ml). Starting values of PMN elastase in plasma amounted to 66.40 ± 14.92 ng/ml in severe trauma, and to 60.52 ± 10.75 ng/ml in MHT showing significant differences only in relation to the control group (23.36 ± 1.53 ng/ml). When correlated with the severity of the later clinical course, the first S-100b measurements exhibited steadily increasing values as demonstrated in MHT outpatients (0.29 ± 0.11 ng/ml), MHT in-hospital patients (0.70 ± 0.19 ng/ml) and MHT intensive care unit patients (5.03 ± 3.18 ng/ml). PMN elastase levels revealed no significant differences concerning the three MHT subgroups.
Thus, in contrast to the general trauma marker PMN elastase, assessment of the specific neuroprotein S-100b early after traumatic insult appears to be a promising laboratory marker for the prognosis of the severity of brain injury in MHT patients. Nevertheless, further investigations are required to better understand its predictive value.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blomquist S, Johnsson P, Luhrs C, Malmkvist G, Solem JO, Ailing C, Stahl E (1997) The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiovasc Vase Anesth 11: 699–703
Borczuk P (1995) Predictors of intracranial injury in patients with mild head trauma. Ann Emerg Med 25: 731–736
Haimoto H, Hosoda S, Kato K (1987) Differential distribution of immunoreactive Sl00-α and S100-β proteins in normal non-nervous human tissues. Lab Invest 57: 489–498
Harad FT, Kerstein MD (1992) Inadequacy of bedside clinical indicators in identifying significant intracranial injury in trauma patients. J Trauma 32: 359–361, discussion 361–363
Ingebrigtsen T, Romner B, Kongstad P, Langbakk B (1995) Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? J Neurol Neurosurg Psychiatry 59: 103–104
Ingebrigtsen T, Romner B (1996) Serial S-100 protein measurements related to early magnetic resonance imaging after minor head injury. J Neurosurg 85: 945–948
Miller EC, Holmes JF, Deriet RW (1997) Utilizing clinical factors to reduce head CT scan ordering for minor head trauma patients. J Emer Med 15: 453–457
Persson L, Haardemark HG, Gustafsson J, Rundstrom G, Mendel-Hartvig I, Esscher T, Pahlman S (1987) S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: Markers of cell damage in human central nervous system. Stroke 18: 911–918
Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A (1998) S-100 serum levels after minor and major head injury. J Trauma 45: 765–767
Shackford SR, Wald SL, Ross SE, Cogbill TH, Hoyt DB, Morris JA, Mucha PA, Pachter HL, Sugerman HJ, O’Malley K (1992) The clinical utility of computed tomographic scanning and neurologic examination in the management of patients with minor head injuries. J Trauma 33: 385–394
Stein SC, Ross SE (1992) Mild head injury: a plea for routine early CT scanning. J Trauma 33: 11–13
Waterloo K, Ingebrigtsen T, Romner B (1997) Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury. Acta Neurochir (Wien) 139: 26–31, discussion 31–32
Waydhas C, Nast-Kolb D, Trupka A, Zettl R, Kick M, Wiesholler J, Schweiberer L, Jochum M (1996) Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 40: 624–630
Wiesmann M, Missler U, Hagenstroem H, Gottmann D (1997) S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) 139: 1155–1160
Woertgen C, Rothoerl RD, Holzschuh M, Metz C, Brawanski A (1997) Comparison of serial S-100 and NSE serum measurements after severe head injury. Acta Neurochir (Wien) 139: 1161–1165
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Wien
About this paper
Cite this paper
Mussack, T. et al. (2000). S-100b as a Screening Marker of the Severity of Minor Head Trauma (MHT) — a Pilot Study. In: Mendelow, A.D., et al. Brain Edema XI. Acta Neurochirurgica Supplements, vol 76. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6346-7_81
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6346-7_81
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7257-5
Online ISBN: 978-3-7091-6346-7
eBook Packages: Springer Book Archive